Lessons Learned from COVID-19 - FC
Global Conference 2024

Revolutionizing Research: Democratizing Clinical Trials

-

The collective clinical research system needs to be thoroughly reconsidered: designed with end users in mind; built to earn trust in research aims and execution; able to maximize the likelihood of engaging the targets—people and communities—stakeholders need to reach. We need to disrupt the paradigm, taking a person-centered, data-driven approach to engage the broadest population of Americans in opportunities to take part in research. New players entering the research enterprise are bringing unique abilities to generate participant and community insights that can influence research objectives, design, and adoption; define, track, and improve participants’ journeys through the research process; measure and drive accountability for outcomes that matter to participants and communities as well as research stakeholders; and reframe research as an opportunity for inclusion rather than a requirement for diversity.

    Moderator

    Image

    Michelle McMurry-Heath

    Founder and CEO, Biotechquity Clinical

    Speakers

    Image

    Silas Buchanan

    CEO, OurHealthyCommunity
    Image

    Martin Landray

    CEO, Protas
    Image

    Susan Monarez

    Deputy Director, Advanced Research Projects Agency for Health
    Image

    Fabian Sandoval

    President and CEO, Emerson Clinical Research Institute
    Image

    Andrew Trister

    Chief Medical and Scientific Officer, Verily Life Sciences